MOR Annual EBIT
-$87.76 M
-$229.12 M-162.08%
31 December 2023
Summary:
As of February 3, 2025, MOR annual earnings before interest & taxes is -$87.76 million, with the most recent change of -$229.12 million (-162.08%) on December 31, 2023. During the last 3 years, it has fallen by -$136.26 million (-280.94%).MOR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Quarterly EBIT
$59.38 M
+$115.99 M+204.87%
31 December 2023
Summary:
As of February 3, 2025, MOR quarterly earnings before interest & taxes is $59.38 million, with the most recent change of +$115.99 million (+204.87%) on December 31, 2023. Over the past year, it has dropped by -$148.34 million (-71.41%).MOR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR TTM EBIT
-$62.41 M
-$148.34 M-172.62%
31 December 2023
Summary:
As of February 3, 2025, MOR TTM earnings before interest & taxes is -$62.41 million, with the most recent change of -$148.34 million (-172.62%) on December 31, 2023. Over the past year, it has dropped by -$190.43 million (-148.74%).MOR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -162.1% | -71.4% | -148.7% |
3 y3 years | -280.9% | +142.0% | -281.1% |
5 y5 years | -24.4% | +142.0% | -281.1% |
MOR EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -157.6% | -75.9% | -133.3% |
MorphoSys AG EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$87.76 M(-162.1%) | $59.38 M(-204.9%) | -$62.41 M(-172.6%) |
Sept 2023 | - | -$56.62 M(+18.5%) | $85.93 M(-54.1%) |
June 2023 | - | -$47.80 M(+175.2%) | $187.38 M(+5.4%) |
Mar 2023 | - | -$17.37 M(-108.4%) | $177.80 M(+38.9%) |
Dec 2022 | $141.36 M(-122.7%) | $207.72 M(+363.4%) | $128.03 M(-121.9%) |
Sept 2022 | - | $44.83 M(-178.1%) | -$585.24 M(-19.4%) |
June 2022 | - | -$57.38 M(-14.5%) | -$725.92 M(-3.8%) |
Mar 2022 | - | -$67.14 M(-86.7%) | -$754.55 M(+6.7%) |
Dec 2021 | -$621.44 M(-1381.3%) | -$505.55 M(+427.4%) | -$707.18 M(+106.1%) |
Sept 2021 | - | -$95.86 M(+11.5%) | -$343.13 M(+21.7%) |
June 2021 | - | -$86.01 M(+334.9%) | -$281.94 M(+21.4%) |
Mar 2021 | - | -$19.77 M(-86.0%) | -$232.17 M(-773.6%) |
Dec 2020 | $48.50 M(-141.1%) | -$141.50 M(+308.2%) | $34.47 M(-70.5%) |
Sept 2020 | - | -$34.66 M(-4.3%) | $116.72 M(-5.9%) |
June 2020 | - | -$36.23 M(-114.7%) | $124.04 M(-19.6%) |
Mar 2020 | - | $246.86 M(-516.7%) | $154.29 M(-231.1%) |
Dec 2019 | -$118.10 M(+67.5%) | -$59.25 M(+116.7%) | -$117.65 M(+5.5%) |
Sept 2019 | - | -$27.34 M(+356.8%) | -$111.52 M(+129.0%) |
June 2019 | - | -$5.99 M(-76.1%) | -$48.70 M(-32.4%) |
Mar 2019 | - | -$25.08 M(-52.8%) | -$72.08 M(+2.3%) |
Dec 2018 | -$70.52 M(-6.9%) | -$53.11 M(-249.7%) | -$70.45 M(+110.0%) |
Sept 2018 | - | $35.47 M(-220.8%) | -$33.54 M(-65.1%) |
June 2018 | - | -$29.36 M(+25.2%) | -$96.05 M(+15.0%) |
Mar 2018 | - | -$23.45 M(+44.7%) | -$83.55 M(+10.1%) |
Dec 2017 | -$75.76 M(+14.4%) | -$16.20 M(-40.0%) | -$75.88 M(-16.2%) |
Sept 2017 | - | -$27.03 M(+60.2%) | -$90.50 M(+16.6%) |
June 2017 | - | -$16.87 M(+6.9%) | -$77.61 M(+9.2%) |
Mar 2017 | - | -$15.78 M(-48.8%) | -$71.05 M(+8.1%) |
Dec 2016 | -$66.23 M(-389.1%) | -$30.82 M(+118.0%) | -$65.73 M(+23.6%) |
Sept 2016 | - | -$14.14 M(+37.1%) | -$53.18 M(+3.9%) |
June 2016 | - | -$10.31 M(-1.4%) | -$51.16 M(+6.1%) |
Mar 2016 | - | -$10.46 M(-42.8%) | -$48.25 M(-297.7%) |
Dec 2015 | $22.91 M | -$18.27 M(+50.8%) | $24.40 M(-39.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2015 | - | -$12.12 M(+63.9%) | $40.22 M(-16.4%) |
June 2015 | - | -$7.39 M(-111.9%) | $48.12 M(-11.8%) |
Mar 2015 | - | $62.19 M(-2636.0%) | $54.55 M(-1117.5%) |
Dec 2014 | -$5.57 M(-139.2%) | -$2.45 M(-41.9%) | -$5.36 M(-41.2%) |
Sept 2014 | - | -$4.22 M(+339.7%) | -$9.11 M(+8.6%) |
June 2014 | - | -$960.50 K(-142.2%) | -$8.39 M(-166.9%) |
Mar 2014 | - | $2.27 M(-136.7%) | $12.55 M(-8.5%) |
Dec 2013 | $14.21 M(+261.3%) | -$6.21 M(+77.2%) | $13.71 M(-46.3%) |
Sept 2013 | - | -$3.50 M(-117.5%) | $25.54 M(-9.8%) |
June 2013 | - | $19.98 M(+480.3%) | $28.32 M(+244.9%) |
Mar 2013 | - | $3.44 M(-38.8%) | $8.21 M(+105.8%) |
Dec 2012 | $3.93 M(-74.8%) | $5.62 M(-877.6%) | $3.99 M(-132.4%) |
Sept 2012 | - | -$723.00 K(+457.4%) | -$12.32 M(-23.6%) |
June 2012 | - | -$129.70 K(-83.4%) | -$16.12 M(-32.8%) |
Mar 2012 | - | -$779.30 K(-92.7%) | -$24.00 M(-260.4%) |
Dec 2011 | $15.65 M(-10.6%) | -$10.69 M(+136.4%) | $14.96 M(-49.7%) |
Sept 2011 | - | -$4.52 M(-43.5%) | $29.72 M(-17.8%) |
June 2011 | - | -$8.01 M(-121.0%) | $36.16 M(-26.9%) |
Mar 2011 | - | $38.18 M(+838.8%) | $49.44 M(+181.0%) |
Dec 2010 | $17.50 M(-3.8%) | $4.07 M(+112.4%) | $17.60 M(+4.3%) |
Sept 2010 | - | $1.91 M(-63.7%) | $16.87 M(-12.8%) |
June 2010 | - | $5.28 M(-16.6%) | $19.36 M(+9.7%) |
Mar 2010 | - | $6.34 M(+89.7%) | $17.64 M(-1.8%) |
Dec 2009 | $18.19 M(-31.1%) | $3.34 M(-24.1%) | $17.96 M(+22.8%) |
Sept 2009 | - | $4.40 M(+23.3%) | $14.62 M(+43.1%) |
June 2009 | - | $3.57 M(-46.4%) | $10.22 M(+53.6%) |
Mar 2009 | - | $6.65 M | $6.65 M |
Dec 2008 | $26.41 M(+108.7%) | - | - |
Dec 2007 | $12.65 M(-87.8%) | - | - |
Dec 2006 | $103.58 M(+135.8%) | - | - |
Dec 2005 | $43.94 M(+5407.8%) | - | - |
Dec 2004 | $797.70 K(-123.1%) | - | - |
Dec 2003 | -$3.46 M(-85.7%) | - | - |
Dec 2002 | -$24.14 M | - | - |
FAQ
- What is MorphoSys AG annual earnings before interest & taxes?
- What is the all time high annual EBIT for MorphoSys AG?
- What is MorphoSys AG annual EBIT year-on-year change?
- What is MorphoSys AG quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MorphoSys AG?
- What is MorphoSys AG quarterly EBIT year-on-year change?
- What is MorphoSys AG TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MorphoSys AG?
- What is MorphoSys AG TTM EBIT year-on-year change?
What is MorphoSys AG annual earnings before interest & taxes?
The current annual EBIT of MOR is -$87.76 M
What is the all time high annual EBIT for MorphoSys AG?
MorphoSys AG all-time high annual earnings before interest & taxes is $152.47 M
What is MorphoSys AG annual EBIT year-on-year change?
Over the past year, MOR annual earnings before interest & taxes has changed by -$229.12 M (-162.08%)
What is MorphoSys AG quarterly earnings before interest & taxes?
The current quarterly EBIT of MOR is $59.38 M
What is the all time high quarterly EBIT for MorphoSys AG?
MorphoSys AG all-time high quarterly earnings before interest & taxes is $246.86 M
What is MorphoSys AG quarterly EBIT year-on-year change?
Over the past year, MOR quarterly earnings before interest & taxes has changed by -$148.34 M (-71.41%)
What is MorphoSys AG TTM earnings before interest & taxes?
The current TTM EBIT of MOR is -$62.41 M
What is the all time high TTM EBIT for MorphoSys AG?
MorphoSys AG all-time high TTM earnings before interest & taxes is $187.38 M
What is MorphoSys AG TTM EBIT year-on-year change?
Over the past year, MOR TTM earnings before interest & taxes has changed by -$190.43 M (-148.74%)